Other News

Cardiac Insight Secures First Cardiology Customers for Its Wearable ECG Sensor, Cardea SOLO™

KIRKLAND, Wash.–(BUSINESS WIRE)– Cardiac Insight, a U.S. developer of wearable medical devices and diagnostic software, announced today that the company has secured its first cardiology customers for its wearable ECG sensor device, Cardea SOLO, in Texas and several other states. Early physician and patient experiences with Cardea SOLO are confirming the […]

EBR Systems, Inc. Raises $50 Million to Complete Global Heart Failure Trial

SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s first and only wireless cardiac pacing system for heart failure, has raised $50 million to conduct the global SOLVE-CRT study. The financing was led by Australian private equity firms M.H. Carnegie & Co. and Brandon Capital Partners and included participation by […]

Xeltis Closes $52M for Replacement Heart Valve Programs

EINDHOVEN, The Netherlands and ZURICH, November 15, 2017 /PRNewswire/ — Xeltis, a clinical-stage medical device company pioneering a restorative approach in heart valve therapy, today announced the completion of an oversubscribed EUR45 million ($52 million) Series C financing. The funding round was led by a global strategic investor with participation […]

How Medical Devices are Changing Our Perception of Precision Medicine

By Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) When you think of precision medicine there are a few things that naturally come to mind: drugs tailored to genetics and certain other genome-based therapies. Medical devices are probably not your first thought. Earlier this year, Medtronic received approval for MR-Conditional Quadripolar Cardiac […]

Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure

ANAHEIM, Calif., Nov. 14, 2017 /PRNewswire/ — Corvia Medical, Inc., a privately-held medical device company that developed a first-in-class transcatheter structural heart device to treat heart failure, today announced that it has enrolled the first patients in its global multicenter trial (REDUCE LAP-HF II) of the Interatrial Shunt Device (IASD) […]

BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission

Santa Monica, CA, Nov. 14, 2017 (GLOBE NEWSWIRE) — BioSig Technologies(OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has engaged Tiffini Wittwer as Chief Regulatory and Compliance Officer […]

Medtronic gains new CPT codes for Venous device in 2018

Medtronic’s VenaSeal Closure System Receives New CPT Codes By Endovascular Today November 13, 2017—Medtronic has advised that their VenaSeal closure system received a favorable new CPT code as a Level 4 vascular procedure as part of the calendar year 2018 Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment and Ambulatory Surgical Center […]

Plaxgen Plaque Array Lipid-Modifying Drugs Study Published in Journal of Visualized Experiments

FREMONT, Calif., Nov. 13, 2017 /PRNewswire/ — Plaxgen Inc,developing flow cytometry-based blood diagnostics for plaque-associated diseases, such as atherosclerosis and Alzheimer’s, announced that new research exploring the effect of lipid-lowering drugs, including statins, on the morphology of cholesterol particles in human serum samples was published in the peer-reviewed journal, “Journal of […]